Sacituzumab govitecan Antibody

SKU: orb2279100

Description

Sacituzumab govitecan (IMMU-132) is a humanized Trop-2-targeting antibody-drug conjugate (ADC) for research into refractory, locally advanced, or metastatic cancers such as breast and urothelial carcinoma. Its anticancer activity and mechanism of action are studied in both in vitro cell-based assays and in vivo tumor models.

Research Area

Immunology & Inflammation

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Recombinant
Molecular Weight	148.74 kDa
Purity	95.00% (May vary between batches)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Concentration	6.48 mg/mL
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

ADCs, Antibody-Drug Conjugates, AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates (ADCs), AntibodyDrugConjugates, AntibodyDrugConjugates(ADCs), IMMU132, IMMU-132, IMMU 132, Sacituzumab govitecan, TROP2

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

643975 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols